We performed a systematic review of 69 studies with information on 2146 sub
jects (454 patients and 1692 healthy volunteers) to examine the maximum pla
sma concentration (C-max) and the time taken to reach maximum concentration
(T-max) for different oral morphine formulations, and to clarify factors c
ontributing to variability. Data from healthy volunteers reflected that see
n for patients but was less variable. There was minimal difference between
single and multiple doses, suggesting no accumulation of morphine. For imme
diate-release morphine there was no difference in either dose-corrected C-m
ax or T-max between solution and tablets, or between different salts. For c
ontrolled-release formulations, little difference was observed between bran
ds. Only for once-daily formulations was there any difference in absorption
between fed and fasted, with a T-max for fed subjects considerably longer
than for fasted. There was no evidence for any difference between values ob
tained by radioimmunoassay (RIA) or high-performance liquid chromatography
(HPLC). (C) U.S. Cancer Pain Relief Committee, 1998.